Rchr
J-GLOBAL ID：201901021465696039   Update date: Aug. 25, 2024

Satoshi Mitarai

Satoshi Mitarai
Affiliation and department：
The Research Institute of Tuberculosis,Japan Anti-tuberculosis Association

About The Research Institute of Tuberculosis,Japan Anti-tuberculosis Association


Research field  (3)： Bacteriology ,  Molecular biology ,  Other
Research keywords  (5)： Diagnostics ,  Non-tuberculosis mycobacterium ,  Mycobacterium tuberculosis ,  Mycobacteriology ,  Clinical Microbiology
Research theme for competitive and other funds  (15)：
  • 2023 - 2029 バイオヒステリシスを考慮した難治性感染症の治療抵抗性要因の解明と普遍的効果を示す次世代型抗菌薬創薬への応用
  • 2023 - 2028 Innovating anti-tuberculosis drug susceptibility testing with a novel and rapid non-culture based phenotypic test using MPT64 biomarker
  • 2023 - 2026 非結核性抗酸菌が抗結核薬に耐性を示すメカニズムの解明と新規治療法開発への応用
  • 2023 - 2026 非結核性抗酸菌が抗結核薬に耐性を示すメカニズムの解明と新規治療法開発への応用
  • 2022 - 2025 わが国の病原体検査の標準化と基盤強化、ならびに、公衆衛生上重要な感染症の国内検査体制維持強化に資する研究
Show all
Papers (302)：
  • Fumiya Watanabe, Yasuhiko Matsumoto, Takashi Sugita, Yuta Morishige, Satoshi Mitarai, Yoshihiko Hoshino, Kazuhiko Hanada. Pharmacokinetics of anti-Mycobacterium avium-intracellulare disease drugs in silkworms. Scientific Reports. 2024. 14. 1
  • Izumi Yamatani, Akio Aono, Keiji Fujiwara, Takahiro Asami, Keisuke Kamada, Yuta Morishige, Yuriko Igarashi, Kinuyo Chikamatsu, Yoshiro Murase, Hiroyuki Yamada, et al. In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates. Microbiology spectrum. 2024. e0008424
  • Fumiya Watanabe, Keiji Fujiwara, Koji Furuuchi, Masashi Ito, Kazuhiko Hanada, Tatsuya Kodama, Akio Aono, Satoshi Mitarai, Takashi Yoshiyama, Atsuyuki Kurashima, et al. Clofazimine Serum Concentration and Safety/Efficacy in Nontuberculous Mycobacterial Pulmonary Disease Treatment. Respiratory Medicine. 2024. 107718-107718
  • Asami Osugi, Aki Tamaru, Takashi Yoshiyama, Tomotada Iwamoto, Satoshi Mitarai, Yoshiro Murase. Mycobacterium tuberculosis is less likely to acquire pathogenic mutations during latent infection than during active disease. Microbiology Spectrum. 2024
  • 山谷 いずみ, 青野 昭男, 藤原 啓司, 浅見 貴弘, 鎌田 啓佑, 森重 雄太, 五十嵐 ゆり子, 近松 絹代, 村瀬 良朗, 山田 博之, et al. M.abscessus subsp.abscessus臨床分離株に対する新規経口βラクタマーゼ阻害薬Xeruborbactamと経口βラクタム薬のin vitroでの併用効果. 結核. 2024. 99. 3. 162-162
ｍore...
MISC (713)：
  • 御手洗 聡. 抗酸菌感染症最近の話題 現在のLTBI治療の考え方. 感染症学雑誌. 2024. 98. 1. 69-69
  • 近松 絹代, 御手洗 聡. 【非結核性抗酸菌症における新展開】診断法 遺伝子検査. 臨床と微生物. 2024. 51. 1. 015-018
  • 小宮 幸作, 御手洗 聡. 【非結核性抗酸菌症における新展開】注目される感染病態 Mycobacterium abscessus. 臨床と微生物. 2024. 51. 1. 041-046
  • 御手洗 聡. 抗酸菌感染症最近の話題 現在のLTBI治療の考え方. 日本化学療法学会雑誌. 2024. 72. 1. 77-78
  • 竹本潔, 鞍谷沙織, 船戸正久, 飯島禎貴, 片山珠美, 柏木淳子, 塩見夏子, 梶原綾, 吉田志緒美, 露口一成, et al. Consideration of a Nosocomial Infection Case Caused by Mycobacterium abscessus. 日本小児科学会雑誌. 2024. 128. 1
ｍore...
Books (44)：
  • 基礎からわかる結核診療ハンドブック
    2022 ISBN:9784498130609
  • 日本の感染症 : 明らかにされたことのこされた課題
    南山堂 2022 ISBN:9784525185817
  • Pulmonary Tuberculosis and Its Prevention
    Springer 2022 ISBN:9789811939945
  • 結核と非結核性抗酸菌症Up to Date
    医歯薬出版 2022
  • 非結核性抗酸菌症マネジメント リアルワールドでのコツと工夫
    日本医事新報社 2020
ｍore...
Lectures and oral presentations  (418)：
  • 皮膚・膿瘍検体から検出された迅速発育性抗酸菌群5例の検討
    (第35回日本臨床微生物学会総会・学術集会 2024)
  • Automatous quantitative MICs determination of Mycobacteria using a reducing chromogenic reagent WST-1
    (International Union against Tuberculosis and Lung Diseases 2023)
  • Evaluation of Deeplex-MycTB using clinical specimens in Japan
    (International Union against Tuberculosis and Lung Diseases 2023)
  • In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis
    (International Union against Tuberculosis and Lung Diseases 2023)
  • Evaluation of the Lung Flute ECO to assist in sputum collection among people with presumptive tuberculosis: a randomized crossover trial
    (International Union against Tuberculosis and Lung Diseases 2023)
ｍore...
Education (2)：
  • 1991 - 1995 Postgraduate school, Nagasaki University
  • 1982 - 1988 Nagasaki University Faculty of Medicine
Professional career (1)：
  • 医学博士 (長崎大学)
Committee career (9)：
  • 2021/02 - 現在 Japanese Society of Chemotherapy Committee member
  • 2018/07 - 現在 日本臨床微生物学会 精度管理委員会
  • 2018/06 - 現在 日本結核・非結核性抗酸菌症学会 結核診療ガイドライン統括委員会
  • 2017 - 現在 薬剤耐性ワンヘルス動向調査検討会 委員
  • 2016/06 - 現在 厚生労働省 外部精度管理事業企画検討委員会
Show all
Awards (6)：
  • 2018/06 - Japanese society for tuberculosis Academic award External quality assessment of anti-tuberculosis drug susceptibility testing for diagnosing extensively drug-resistant Mycobacterium tuberculosis
  • 2018 - Japan Veterinary Medical Association Incentive award
  • 2017 - National Centre for Communicable Diseases Medal of Honour, National Centre for Communicable Disease, Mongolia
  • 2011/05 - Ministry of Health, Mongolia Highest medal of honor
  • 2004/03 - Japanese society for tropical medicine Incentive award Drug Susceptibilities and Clinical Manifestations of Mycobacterium tuberculosis in Zambia 2000
Show all
Association Membership(s) (8)：
International Union Against Tuberculosis and Lung Diseases ,  American Society for Microbiology ,  JAPANESE SOCIETY OF TROPICAL MEDICINE ,  JAPANESE SOCIETY FOR BACTERIOLOGY ,  THE JAPANESE ASSOCIATION FOR INFECTIOUS DISEASES ,  THE JAPANESE SOCIETY FOR CLINICAL MICROBIOLOGY ,  JAPANESE SOCIETY OF CHEMOTHERAPY ,  THE JAPANESE SOCIETY FOR TUBERCULOSIS AND NONTUBERCULOUS MYCOBACTERIOSIS
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM